Connecticut Children's Hospital

Hartford, Connecticut 06106

Use our guide to learn which trials are right for you!

We've found
11 trials
at this facility
Neuroblastoma Clinical Trial
Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
Status: Enrolling
Updated: 10/12/2012
mi
from
Hartford, CT
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Status: Enrolling, Phase II
Updated: 10/7/2015
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Tolcapone With Oxaliplatin for Neuroblastoma or Medulloblastoma
Status: Enrolling, Phase I
Updated: 12/14/2015
mi
from
Hartford, CT
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Neuroblastoma Maintenance Therapy Trial
Status: Enrolling, Phase II
Updated: 2/16/2016
mi
from
Hartford, CT
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Pediatric Alliance for International Neurogastrointestinal Functional Research
Status: Enrolling
Updated: 6/21/2011
mi
from
Hartford, CT
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
Status: Enrolling, Phase II
Updated: 11/8/2015
mi
from
Hartford, CT
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Enrolling, Phase I
Updated: 2/16/2016
mi
from
Hartford, CT
Click here to add this to my saved trials
Neuroblastoma Recurrent Clinical Trial
Study of DFMO in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma
Status: Enrolling, Phase I, II
Updated: 2/16/2016
mi
from
Hartford, CT
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
Status: Enrolling, Phase I, II
Updated: 1/18/2016
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
Status: Enrolling, Phase I, II
Updated: 1/18/2016
mi
from
Hartford, CT
Click here to add this to my saved trials